Adding Flying Wings: Butterfly-Shaped NIR-II AIEgens with Multiple Molecular Rotors for Photothermal Combating of Bacterial Biofilms.
Dingyuan YanYue HuangJian-Yu ZhangQian WuGuangjie SongJian JiQiao JinDong WangBen-Zhong TangPublished in: Journal of the American Chemical Society (2023)
The ever-increasing threats of multidrug-resistant bacteria and their biofilm-associated infections have bred a desperate demand for alternative remedies to combat them. Near-infrared (NIR)-absorbing photothermal agent (PTAs)-mediated photothermal therapy (PTT) is particularly attractive for biofilm ablation thanks to its superiorities of noninvasive intervention, satisfactory antibacterial efficiency, and less likelihood to develop resistance. Herein, three butterfly-shaped aggregation-induced emission luminogens (AIEgens) with balanced nonradiative decay (for conducting PTT) and radiative decay (for supplying fluorescence in the NIR-II optical window) are rationally designed for imaging-assisted photothermal obliteration of bacterial biofilms. After being encapsulated into cationic liposomes, AIEgens-fabricated nanoparticles can eradicate a wide spectrum of biofilms formed by Gram-positive bacteria (methicillin-resistant Staphylococcus aureus and Enterococcus faecalis ) and Gram-negative bacteria ( Escherichia coli and Pseudomonas aeruginosa ) upon an 808 nm laser irradiation. In vivo experiments firmly demonstrate that the NIR-II AIE liposomes with excellent biocompatibility perform well in both the P. aeruginosa biofilm-induced keratitis mouse model and the MSRA biofilm-induced skin infection mouse model.
Keyphrases
- drug release
- pseudomonas aeruginosa
- candida albicans
- photodynamic therapy
- biofilm formation
- staphylococcus aureus
- mouse model
- drug delivery
- methicillin resistant staphylococcus aureus
- fluorescence imaging
- acinetobacter baumannii
- cystic fibrosis
- multidrug resistant
- escherichia coli
- high glucose
- high resolution
- fluorescent probe
- gram negative
- cancer therapy
- randomized controlled trial
- drug induced
- endothelial cells
- klebsiella pneumoniae
- radiation therapy
- atrial fibrillation
- quantum dots
- living cells
- silver nanoparticles
- anti inflammatory